U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07116902) titled 'Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes' on June 13.
Brief Summary: Currently, clinicians are unable to predict a patient's risk of long-term disease progression and development of a long-term complication based on the data that is available to them. The first aim of this is to develop and validate an Artificial Intelligence (AI) powered prediction model for Type 2 Diabetes (T2D) disease progression using existing data from previously collected studies and real-world electronic health medical data. Investigators will use clinical, pharmacologic, and genomic factors to develo...